This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marques, M. R. Articles by Attardi, L. D. Search for Related Content PubMed PubMed Citation Articles by Marques, M. R. Articles by Attardi, L. D.

Mice Lacking the p53/p63 Target Gene Perp Are Resistant to Papilloma Development

¹ Department of Radiation Oncology, Division of Radiation and Cancer Biology and ² Department of Genetics, Stanford University School of Medicine, Stanford, California; and ³ Department of Pathology, Harvard Medical School, Boston, Massachusetts

Requests for reprints: Laura D. Attardi. Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305. Phone: 650-725-8424; Fax: 650-723-7382; E-mail: attardi{at}stanford.edu.

Perp is a target of the p53 tumor suppressor involved in the DNA damage-induced apoptosis pathway. In addition, Perp is a target of the p53-related transcription factor p63 during skin development, where it participates in cell-cell adhesion mediated through desmosomes. Here we test the role of Perp in tumorigenesis in a two-step skin carcinogenesis model system. We find that mice lacking Perp in the skin are resistant to papilloma development, displaying fewer and smaller papillomas than wild-type mice. Proliferation levels, apoptotic indices and differentiation patterns are similar in the skin of treated Perp-deficient and wild-type mice. Instead, impaired adhesion through aberrant desmosome assembly may explain the diminished tumor development in the absence of Perp. These studies indicate that in certain contexts, Perp is required for efficient carcinogenesis and suggest a role for intact cell-cell adhesion in supporting tumor development in these settings.

This article has been cited by other articles:

				Z. Saifudeen, S. Dipp, J. Stefkova, X. Yao, S. Lookabaugh, and S. S. El-Dahr p53 Regulates Metanephric Development J. Am. Soc. Nephrol., November 1, 2009; 20(11): 2328 - 2337. [Abstract] [Full Text] [PDF]

				K. Singaravelu, K. Devalaraja-Narashimha, B. Lastovica, and B. J. Padanilam PERP, a p53 proapoptotic target, mediates apoptotic cell death in renal ischemia Am J Physiol Renal Physiol, April 1, 2009; 296(4): F847 - F858. [Abstract] [Full Text] [PDF]